Page last updated: 2024-10-23

bretylium and Coronary Disease

bretylium has been researched along with Coronary Disease in 2 studies

bretylium: RN given refers to parent cpd
bretylium : A quaternary ammonium cation having 2-bromobenzyl, ethyl and two methyl groups attached to the nitrogen. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gregorini, L1
Fajadet, J1
Robert, G1
Cassagneau, B1
Bernis, M1
Marco, J1
Coker, SJ1

Other Studies

2 other studies available for bretylium and Coronary Disease

ArticleYear
Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents.
    Circulation, 1994, Volume: 90, Issue:2

    Topics: Angioplasty, Balloon, Coronary; Bretylium Compounds; Coronary Angiography; Coronary Disease; Coronar

1994
Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium.
    Journal of pharmacological methods, 1989, Volume: 21, Issue:4

    Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Bretylium Compounds; Coronary Disease; Coronary Vessels;

1989